Spatial omics refers to techniques that can map the spatial organization and interactions of biomolecules like RNA, DNA and proteins at high resolution in tissue samples and whole organisms. Spatial omics tools enable researchers in basic research and drug development to gain a deeper mechanistic understanding of biological processes and disease pathology at the tissue and cellular level. The global spatial omics market offers products like instruments, software and reagents and kits required for spatial transcriptomics, proteomics and genomics applications. The growing investments into precision medicine and need for advanced tools to better understand disease pathology at micro and macro levels is driving the demand for spatial omics solutions.
The global spatial omics Market is estimated to be valued at US$ 292.1 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Opportunity:
The opportunity to advance precision medicine through insights gained from spatial analysis of biomolecules is fueling investments into spatial omics. Precision medicine aims to leverage insights into how genes, environment and lifestyle factors influence people's health to allow for targeted disease management and treatment. Spatial omics provides high resolution views of molecular changes in tissues and can help discover disease subtypes, biomarkers and drug targets. This can enable development of personalized diagnostics and therapeutics. The ability of spatial omics to accelerate precision medicine approaches by offering micro and macro level disease insights is expected to drive significant demand and support the high growth of this market over the forecast period.
Porter's Analysis
Threat of new entrants: Low capital requirements and established value chain pose low threat to existing players. However, new technologies threaten status-quo.
Bargaining power of buyers: Large biopharmaceutical firms have strong bargaining power due to bulk purchases. However, rapid commercialization reduces buyer power over innovators.
Bargaining power of suppliers: Specialized equipment makers face low threat from backward integration but their innovations influence market.
Threat of new substitutes: Emerging spatial profiling and other omics techniques may replace conventional bulk methods. However, integrated solutions hold promise.
Competitive rivalry: Intense competition exists among innovators to introduce proprietary platforms. Acquisitions and partnerships define strategy.
SWOT Analysis
Strengths: Massive scope in drug discovery and diagnostics. Growing R&D investments by pharma giants.
Weaknesses: High costs limit access. Scarce expertise hampers analysis and interpretation.
Opportunities: Underpenetrated Asian and Latin American markets offer scope. Multi-omics approach and AI integration open new avenues.
Threats: Stringent regulations for clinical use. Bulk analyses techniques compete on pricing.
Key Takeaways
The Global Spatial Omics Market is expected to witness high growth during the forecast period due to rising pharmaceutical R&D expenditures and growing focus on targeted therapy development. The global spatial omics Market is estimated to be valued at US$ 292.1 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023 to 2030.
North America dominates presently due to extensive research and availability of advanced healthcare systems in the US and Canada. The Asia Pacific region is anticipated to grow at the fastest pace owing to rising healthcare investments, westernization, and increasing collaborations between local and global market players in countries such as China, Japan and India.
Key players operating in the Spatial Omics Market are 10x Genomics, Akoya Bioscience Inc., Biognosys AG, BioSpyder Technologies, Bio-Techne, Bruker, Brooks Automation Inc., Danaher Corporation, and Diagenode. 10x Genomics leads with its Chromium platform for spatially resolved transcriptomics and proteomics. Akoya Biosciences offers spatial profiling tools through mergers. Regional leaders include Japanese firms like Sysmex which strategize acquisitions and new product launches to gain market share.
Get more insights on this topic: https://www.insightprobing.com/spatial-omics-market-demand-share-analysis/
